Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy. Acta Haematol 2018;139(3):171-175
Date
03/30/2018Pubmed ID
29597188Pubmed Central ID
PMC6388419DOI
10.1159/000487879Scopus ID
2-s2.0-85045039013 (requires institutional sign-in at Scopus site)Author List
Schneidewend R, Hosking P, Brazauskas R, Peterson J, Beaudin C, Michaelis L, Atallah E, Hari P, Carlson KAuthors
Ehab L. Atallah MD Professor in the Medicine department at Medical College of WisconsinRuta Brazauskas PhD Associate Professor in the Institute for Health and Equity department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Laura Michaelis MD Chief, Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAged
Biomarkers, Tumor
Female
Genetic Markers
Humans
In Situ Hybridization, Fluorescence
Induction Chemotherapy
Leukemia, Myeloid, Acute
Male
Middle Aged
Odds Ratio
Young Adult